Cite
MLA Citation
Sebastian Bauer et al.. “Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial.” Journal of clinical oncology, vol. 40, no. 34, 2022, pp. 3918–3928. http://access.bl.uk/ark:/81055/vdc_100171886696.0x000015